Sponsor or institution

Clinical trials and research at Fundación GECP

• 7Clinical trials
• 1Country

Newest trials

All recruiting trials (7)

• Tarlatamab as maintenance treatment after chemo-radiotherapy for limited-stage small-cell lung cancer.

  This trial will test whether giving tarlatamab after chemo-radiotherapy helps people with limited-stage small-cell lung cancer stay progression-free longer.

  Recruiting at 20 sites Phase 2 Fundación GECP · Albacete, Albacete and 19 other locations · NCT07242547

• Neoadjuvant atezolizumab with carboplatin and paclitaxel followed by atezolizumab maintenance for Stage III non-small cell lung cancer

  This trial tests whether giving atezolizumab with carboplatin and paclitaxel before possible surgery, then continuing atezolizumab afterward, helps people with stage III non-small cell lung cancer stay free of disease progression longer.

  Recruiting at 20 sites Phase 2 Fundación GECP · Alicante, Alicante and 20 other locations · NCT07153445

• Cemiplimab guided by ctDNA levels (PALACE)

  This study will see if starting adults with advanced (stage IIIB/C or IV) non-small cell lung cancer and PD-L1 ≥50% on cemiplimab, then using ctDNA and early scans to decide whether to add chemotherapy, can improve overall survival.

  Recruiting at 19 sites Phase 2 Fundación GECP · Alicante, Alicante and 19 other locations · NCT06917573

• Examining immune responses in advanced lung cancer patients after treatment

  This study looks at how the immune system responds in patients with advanced lung cancer after they receive a combination of chemotherapy, radiation, and immunotherapy to see how these treatments work together.

  Recruiting at 22 sites Fundación GECP · Ferrol, A Coruña and 21 other locations · NCT06634199

• Treatment for lung cancer patients who had surgery but are not disease-free

  This study is testing two new immunotherapy treatments for lung cancer patients who have had surgery but still have some disease to see if they can help them stay cancer-free longer.

  Recruiting at 31 sites Phase 3 Fundación GECP · Alicante, Alicante and 31 other locations · NCT06431633

• Treatment of advanced lung cancer with Sotorasib for patients unable to undergo chemotherapy.

  This study is testing if a new drug called Sotorasib can help people with advanced lung cancer who can’t have chemotherapy live longer without their disease getting worse.

  Recruiting at 20 sites Phase 2 Fundación GECP · Alicante, Alicante and 19 other locations · NCT05398094

• Evaluating the response to neoadjuvant treatment in stage IIIA lung cancer patients

  This study is trying to see how well neoadjuvant treatment works for people with stage IIIA lung cancer by looking at their tissue samples to understand if it helps them live longer and stay cancer-free.

  Recruiting at 17 sites Fundación GECP · A Coruña, A Coruña and 16 other locations · NCT05167487

Quick answers

How many clinical trials run by Fundación GECP are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Spain. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 4, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →